trial

The IM-ZBULLE Study : " Z-track " and " Airlock " Techniques During Intramuscular Injection of Haloperidol Decanoate

NCTId NCT05995457
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 84 (estimated)
Sponsored by Centre Hospitalier St Anne
Primary completion 2024-09-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
84 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2023-09-01
Primary completion
2024-09-30
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Haloperidol

Sponsors

Centre Hospitalier St AnneLead Sponsor
Groupe Hospitalier Paul GuiraudCollaborator
Etablissement Public de Santé Barthélemy DurandCollaborator

Investigators

1
Rayan BCHINIPrincipal Investigator

Sites

1 total
Villejuif, France

Facts & assertions

4 sourced
Enrollment
84
Phase
NA
Primary Completion Date
2024-09-30
Status
UNKNOWN
relationships
The graph out of here
drug
Haloperidol
drug
lead_sponsor
Centre Hospitalier St Anne
company
collaborator
Groupe Hospitalier Paul Guiraud
company
Etablissement Public de Santé Barthélemy Durand
company
indication
Schizophrenia; Psychosis
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Rayan BCHINI
person